P2 Science Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $23M

  • Investors
  • 22

P2 Science General Information

Description

Developer of specialty chemical products designed to be used in the production of diversified green chemicals. The company's chemicals are produced on intensified process technologies for converting renewable feedstocks into value, specialty chemicals, including flavor and fragrance ingredients, cosmetics ingredients and renewable monomers, enabling businesses to decarbonize the chemical industry, using the power of sustainable resources.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Research Drive
  • Woodbridge, CT 06525
  • United States
+1 (855)
Primary Industry
Specialty Chemicals
Other Industries
Environmental Services (B2B)
Personal Products
Corporate Office
  • 4 Research Drive
  • Woodbridge, CT 06525
  • United States
+1 (855)

P2 Science Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

P2 Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 14-May-2026 $23M Completed Generating Revenue
16. Accelerator/Incubator Completed Generating Revenue
15. Later Stage VC 17-Mar-2025 Completed Generating Revenue
14. Later Stage VC (Series C3) 27-Nov-2024 Completed Generating Revenue
13. Later Stage VC (Series C3) 23-Feb-2023 Completed Generating Revenue
12. Later Stage VC (Series C3) 18-Nov-2022 Completed Generating Revenue
11. Later Stage VC (Series C2) 29-Jan-2021 Completed Generating Revenue
10. Debt - General 08-Jun-2020 Completed Generating Revenue
9. Later Stage VC (Series C) 18-Nov-2019 $15.6M $31.1M Completed Generating Revenue
8. Later Stage VC (Series B) 10-Feb-2017 $11.3M $15.5M Completed Generating Revenue
To view P2 Science’s complete valuation and funding history, request access »

P2 Science Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-2
Series C-1B
Series C-1A
Series B 23,649,230 $0.001000 8% $0.52 $0.52 $0.52 30.31%
Series A 4,883,240 $0.001000 8% $0.84 $0.84 $0.84 6.26%
To view P2 Science’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

P2 Science Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty chemical products designed to be used in the production of diversified green chemicals. The compa
Specialty Chemicals
Woodbridge, CT
36 As of 2026

Philadelphia, PA
 

East Stroudsburg, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

P2 Science Competitors (8)

One of P2 Science’s 8 competitors is INOLEX, a Private Debt Financed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
INOLEX Private Debt Financed Philadelphia, PA
Vigon International Private Equity-Backed East Stroudsburg, PA
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
International Flavors & Fragrances Corporation New York, NY
Ecovia Bio Venture Capital-Backed Livonia, MI
You’re viewing 5 of 8 competitors. Get the full list »

P2 Science Patents

P2 Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025255253-A1 Novel ester compounds Pending 04-Jun-2024
WO-2025255257-A1 Terpene alcohol ester compounds Pending 04-Jun-2024
EP-4662194-A1 New method for ozonolysis and reductive quenching of ozonides Pending 06-Feb-2023
US-20260225982-A1 New method for ozonolysis and reductive quenching of ozonides Pending 06-Feb-2023
WO-2024167957-A1 New method for ozonolysis and reductive quenching of ozonides Inactive 06-Feb-2023 C07C45/40
To view P2 Science’s complete patent history, request access »

P2 Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

P2 Science Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cycle Capital Management Venture Capital Minority
Emerald Technology Ventures Venture Capital Minority
GS Futures Corporate Venture Capital Minority
Sofinnova Partners Venture Capital Minority
Cambridge Associates PE-Backed Company Minority
You’re viewing 5 of 22 investors. Get the full list »

P2 Science FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process